NorwayNorway

Norway

05.03.2004

Oslo - Oslo-based Affitech AS, a human antibody discovery and develop-ment company, and the Norwegian Radium Hospital received in mid-February some Euro704,000 from FUGE (Norwegian national functional genomics program) to carry out research on the development of new cancer therapeutics, vaccines and diagnostics.

NorwayNorway

05.04.2011

Oslo – Norwegian Algeta ASA has entered a research collaboration with Genzyme to evaluate the potential of its Thorium platform Under the terms of the agreement, Genzyme will provide access to a novel tumour-targeting antibody,...

NorwayNorway

05.04.2011

Trondheim – Norway-based APIM Therapeutics AS has received a follow-up investment from Sarsia Seed, one of its previous investors. APIM focusses on novel drug candidates that potentiate the action of current chemo­therapeutics to...

NorwayNorway

04.11.2010

Oslo – Norwegian diagnostic specialist DiaGenic ASA has raised NOK70m (EUR 8.5m) through the sale of 140 million shares at NOK0.50 per share in a private placement to new and existing investors. DnB NOR Markets acted as manager...

NorwayNorway

03.11.2010

Oslo – The Oslo Cancer Cluster and the Shanghai Institute of Materia Medica (SIMM), have signed a memorandum of understanding aimed at accelerating the development and adoption of new cancer therapies. Overall, the collaboration...

NorwayNorway

18.09.2010

Oslo/Berlin – Algeta is cashing in on its lead product Alpharadin, a targeted alpha-radiopharmaceutical in clinical trials for treating bone metastases in cancer patients. Bayer Schering Pharma has agreed to pay the Norwegian...

NorwayNorway

11.07.2010

Lysaker – Norwegian biopharmaceutical company PCI Biotech Holding ASA has strengthened the company’s equity by a11m (NOK90m) through a share issue of 2.25 million shares with preemptive subscription rights for existing...

Displaying results 11 to 20 out of 92

< Previous 11-20 Next >

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-norway/browse/1/article/norway-5.html

Whitepaper

Video

All videos

Product of the week

Products

Events

All Events

Stock list

All quotes

TOP

  • IMMUNICUM AB (S)33.00 SEK32.00%
  • ZEALAND PHARMA (DK)151.00 DKK4.86%
  • CYTOS (CH)0.46 CHF4.55%

FLOP

  • OREXO (S)53.25 SEK-28.76%
  • THERAMETRICS (CH)0.06 CHF-14.29%
  • ZELTIA (E)3.69 EUR-8.44%

TOP

  • CHRONTECH PHARMA (S)0.02 SEK100.0%
  • DBV TECHNOLOGIES (F)80.79 EUR53.2%
  • BIOTIE THERAPEUTICS (FI)0.22 EUR37.5%

FLOP

  • BIOTEST (D)26.60 EUR-61.7%
  • BIOTECH PHARMACON (N)9.30 NOK-46.9%
  • EVOCUTIS (UK)0.16 GBP-27.3%

TOP

  • ADOCIA (F)89.23 EUR535.1%
  • DBV TECHNOLOGIES (F)80.79 EUR324.1%
  • FORMYCON (D)28.54 EUR319.1%

FLOP

  • CHRONTECH PHARMA (S)0.02 SEK-77.8%
  • NEUROVIVE PHARMACEUTICAL AB (S)22.50 SEK-72.0%
  • NEOVACS (F)1.04 EUR-69.7%

No liability assumed, Date: 04.08.2015

Current issue

All issues